176 EUR
7
4.14%
Last update Dec 5, 9:26 PM CET
Market closed
Day range
176
176
Previous close
169
Open
176
Access this stock data via API
Subscribe
Ascendis Pharma A/S
176.00
7
4.14%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 363.6M 266.7M 51.2M 7.8M
Cost of revenue 44.3M 44.4M 12.1M 3.5M
Gross profit 319.4M 222.3M 39.0M 4.3M
Operating expense
Research & development 307.0M 413.5M 379.6M 295.9M
Selling general and admin 284.5M 258.8M 215.9M 160.2M
Other operating expenses
Operating income -278.8M -455.5M -561.8M -451.8M
Non operating interest income
Income 14.4M 16.9M 7.4M 692K
Expense 65.5M 44.1M 30.7M 3.9M
Other income expense -54.6M 8.6M 7.3M 71.1M
Pretax income -373.2M -474.1M -577.8M -383.9M
Tax provision 4.8M 7.3M 5.4M -367K
Net income -378.1M -481.4M -583.2M -383.6M
Basic EPS -6.5 -8.6 -10.4 -7
Diluted EPS -6.5 -8.6 -10.4 -7
Basic average shares 57.9M 56.3M 56.1M 54.8M
Diluted average shares 57.9M 56.3M 56.1M 54.8M
EBITDA -255.5M -438.2M -554.1M -423.7M
Net income from continuing op. -378.1M -481.4M -583.2M -383.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 48 minutes

02:11
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).